These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 19265346)

  • 21. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
    Book C; Karlsson M; Akesson K; Jacobsson L
    Scand J Rheumatol; 2008; 37(4):248-54. PubMed ID: 18612924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoid-induced osteoporosis.
    Tamura Y; Okinaga H; Takami H
    Biomed Pharmacother; 2004 Nov; 58(9):500-4. PubMed ID: 15511606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Underdiagnosis and under-treatment of osteoporosis following fragility fracture.
    Aboyoussef M; Vierkoetter KR
    Hawaii Med J; 2007 Jul; 66(7):185-7. PubMed ID: 17879856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents.
    Brown JJ; Zacharin MR
    J Paediatr Child Health; 2005 Nov; 41(11):580-2. PubMed ID: 16398842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticosteroid-induced osteoporosis in neurology patients.
    Gallagher DA; Sturrock A
    Clin Neurol Neurosurg; 2007 Feb; 109(2):218-9. PubMed ID: 16949735
    [No Abstract]   [Full Text] [Related]  

  • 26. [Glucocorticoid induced osteoporosis in childhood: prophylaxis and treatment].
    Tanaka H
    Clin Calcium; 2009 Apr; 19(4):569-73. PubMed ID: 19329838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of glucocorticoid-induced osteoporosis in childhood].
    Tanaka H
    Clin Calcium; 2006 Nov; 16(11):1879-86. PubMed ID: 17079856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Activate vitamin D3 or bisphosphonate in glucocorticoid-induced osteoporosis].
    Imanishi Y; Nishizawa Y
    Clin Calcium; 2006 Nov; 16(11):1844-50. PubMed ID: 17079851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis.
    Blalock SJ; Norton LL; Patel RA; Dooley MA
    Arthritis Rheum; 2005 Oct; 53(5):732-9. PubMed ID: 16208664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of a strategy for the management of accompanying osteoporosis after inpatient treatment of fragility fractures].
    Bahrs C; Türk A; Eingartner C; Weise K; Rolauffs B; Stuby F
    Z Orthop Unfall; 2008; 146(1):52-8. PubMed ID: 18324582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is new in the treatment of steroid-induced osteoporosis?
    Liu RH; Werth VP
    Semin Cutan Med Surg; 2006 Jun; 25(2):72-8. PubMed ID: 16908396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis, clinical feature and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis].
    Nakayama H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():499-503. PubMed ID: 18161156
    [No Abstract]   [Full Text] [Related]  

  • 33. Glucocorticoid-induced osteoporosis.
    Berris KK; Repp AL; Kleerekoper M
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):446-50. PubMed ID: 17982350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary and secondary prophylaxis to the use of inhaled glucocorticoid in primary health care.
    Nielsen BR; Jørgensen NR; Schwarz P
    J Asthma; 2008 Aug; 45(6):519-22. PubMed ID: 18612907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Medical prophylaxis and treatment of steroid induced osteoporosis].
    Rødevand E; Mikkelsen K; Nordvåg BY; Haga HJ; Førre Ø; Johnsen V; Kvien TK
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1643-5. PubMed ID: 15976829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of glucocorticoid treatment on focal and systemic bone loss in rheumatoid arthritis.
    Di Munno O; Delle Sedie A
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):43-7. PubMed ID: 18791351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs.
    Adler RA; Hochberg MC
    Arch Intern Med; 2003 Nov; 163(21):2619-24. PubMed ID: 14638562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoid-induced bone loss in dermatologic patients: an update.
    Summey BT; Yosipovitch G
    Arch Dermatol; 2006 Jan; 142(1):82-90. PubMed ID: 16415391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate].
    Benucci M; Dolenti S; Saviola G; Manfredi M
    Recenti Prog Med; 2006 Jan; 97(1):24-7. PubMed ID: 16535926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Secondary osteoporosis. Guidelines for glucocorticoid-induced osteoporosis].
    Tanaka I; Oshima H
    Clin Calcium; 2007 May; 17(5):779-84. PubMed ID: 17471010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.